Zostavax safety advisory
The Therapeutic Goods Administration (TGA) have reiterated their advice that Zostavax should not be administered to immunocompromised individuals as it is associated with a risk of mild-serious complications. This advice follows a report of a new case of a patient who was taking hydroxychloroquine and a low dose of prednisolone who died three weeks after receiving the Zostavax vaccine. Whilst it was found that the Zostavax was administered in line with existing recommendations it is important that health professionals are aware of the potential of this kind of very rare adverse event.
在这里阅读更多内容：
And for more information on Zoster and to access the Zostavax GP Decision Aid refer to the MVEC：带状疱疹 immunisation reference page.
反映 NIP 变化的 MVEC 免疫参考页面更新 2020 年 7 月 1 日
我们更新了以下 MVEC 免疫参考页面，以反映自 2020 年 7 月 1 日起对国家免疫计划 (NIP) 的更改：
- MVEC：原住民和托雷斯海峡岛民免疫建议
- MVEC：阿斯普利亚
- MVEC：患有心脏病的儿童
- MVEC：脑膜炎球菌病和疫苗
- MVEC：特殊风险和免疫抑制患者的脑膜炎球菌疫苗
- MVEC：早产儿免疫接种
- MVEC：推荐购买 20 岁以下的额外疫苗（无资金）
流感疫苗和鸡蛋过敏
Based on prospective and retrospective studies of influenza vaccination in those with and without egg allergy (including egg anaphylaxis), the presence of egg allergy does not increase the risk of allergic reactions to the influenza vaccine and can be administered in a community immunisation setting, as a single dose, followed by the recommended 15 minute observation period.
For further information please see the following:
新的免疫参考页面：皮内疫苗接种
皮内疫苗接种是将疫苗输送到皮肤外层，用于少数疫苗，例如卡介苗和乙型肝炎（针对无反应者）。
要了解有关皮内疫苗接种、哪些疫苗可以通过这种方式接种以及如何接种皮内疫苗的更多信息，请参阅我们新的免疫接种参考页面， MVEC：皮内免疫接种.
药剂师免疫更新
维多利亚州药剂师免疫人员现在被授权为 10 岁及以上的患者接种流感疫苗，为 15 岁及以上的患者接种含百日咳、麻疹-腮腺炎-风疹和脑膜炎球菌的 ACWY 疫苗。
有关更多信息，请参阅最新的 DHHS 秘书批准：药剂师免疫员。
另请参阅我们的更新 MVEC：药剂师免疫页面 和 MVEC：流感疫苗建议 页。
我如何知道在 2020 年流感季节使用哪个流感品牌？
| 年龄阶层 | 品牌和剂量 | |||||
|---|---|---|---|---|---|---|
| FluQuadri® 0.5ml（赛诺菲） | Vaxigrip Tetra® 0.5ml（赛诺菲） | Fluarix Tetra® 0.5ml (GSK) | Afluria Quad® 0.5ml（Seqirus） | Influvac Tetra® 0.5ml（Mylan） | Fluad® Quad 0.5ml (Seqirus) | |
| <6个月 | 太小不能接种疫苗 (N/A) | |||||
| 6 至 35 个月（<3 年）*¥ | 0.5毫升 | 0.5毫升 | 0.5毫升 | 不适用 | 不适用 | 不适用 |
| ≥3 年至 <5 年 *¥ | 0.5毫升 | 0.5毫升 | 0.5毫升 | 不适用 | 0.5毫升 | 不适用 |
| ≥5 至 <65 岁 *¥ | 0.5毫升 | 0.5毫升 | 0.5毫升 | 0.5毫升 | 0.5毫升 | 不适用 |
|
≥65岁 |
0.5毫升 | 0.5毫升 | 0.5毫升 | 0.5毫升 | 0.5毫升 | 0.5ml# |
有关 2020 年季节性流感疫苗的更多信息，请参阅我们的 MVEC 资源： 流感疫苗建议 页
Influenza vaccine 2020 FAQ's
MVEC’s Frequently Asked Questions for the 2020 Influenza season are now available online
To view our reference page please click on the following link:
MVEC: Influenza vaccines: Frequently asked questions
MVEC Influenza recommendations 2020
For information on influenza immunisation for the 2020 season, including age specific brands, dosing guidelines and advice for at risk groups, please refer to:
MVEC: Influenza vaccine recommendations 2020
New immunisation reference page: Gelatin allergy and vaccines
Gelatin in vaccines can cause allergic reactions therefore people with severe allergies to gelatin should avoid gelatin-containing vaccines. See our new Gelatin allergy and vaccines reference page for more information.
MVEC: Gelatin allergy & vaccines
Maternal vaccination during pregnancy reference page update
We have recently updated our Vaccines in pregnancy immunisation reference page. Influenza and pertussis vaccines are recommended in pregnancy. All live vaccines are contraindicated in pregnancy. Read our updated page for further information!